UnitedHealth Group Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2020
NCT04353037
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Daniel Griffin | Daniel Griffin, MD PhD | ProHealth Care Associates | UnitedHealth Group